Share Your Story.
Have you, a family member, or a friend been impacted by the Center for Medicare & Medicaid Services’ decision in March 2023 to cutback coverage for non-invasive patient blood tests for transplant surveillance?
Have you or your loved one had to undergo a painful, time-consuming biopsy instead of being able to receive these non-invasive, molecular blood tests for monitoring rejection?
If so, our coalition would like to learn more about your story.
Please fill out the form below and we will be in touch with you to learn more about how this important issue is impacting you or your loved one.